Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Clinical Therapeutics|March 2, 2006
Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label studyJonathan M Meyer, Gahan Pandina, Cynthia A Bossie, et al.
Advances in Therapy|November 5, 2017
Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with SchizophreniaHongyan Zhang, Ibrahim Turkoz, Jianmin Zhuo, et al.
Biometrics|May 26, 2017
Global sensitivity analysis for repeated measures studies with informative drop-out: A semi-parametric approachDaniel Scharfstein, Aidan McDermott, Iván Díaz, et al.
The Journal of Nervous and Mental Disease|December 23, 2016
Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective DisorderCynthia A Bossie, Ibrahim Turkoz, Larry Alphs, et al.
Community Mental Health Journal|March 9, 2007
Evaluation of a treatment manual for risperidone long-acting injectableJohn P Docherty, Robert Jones, Ibrahim Turkoz, et al.
Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) studyAnirban Basu, Carmela Benson, Ibrahim Turkoz, et al.
Neuropsychiatric Disease and Treatment|April 10, 2019
Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulationAbigail I Nash, Ibrahim Turkoz, Adam J Savitz, et al.
The Journal of Nervous and Mental Disease|December 20, 2007
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectableGeorges Gharabawi, Cynthia Bossie, Ibrahim Turkoz, et al.
BMC Psychiatry|February 9, 2011
Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysisIbrahim Turkoz, Cynthia A Bossie, Jean-Pierre Lindenmayer, et al.
Expert Opinion on Pharmacotherapy|August 9, 2019
A post hoc analysis on hospitalization risk in Asian patients with schizophrenia switching to once-monthly paliperidone palmitate from oral antipsychoticsNan Li, Jian Min Zhuo, Ibrahim Turkoz, et al.
Pageof 10